Replies to post #105872 on Biotech Values

[EyeamBill]

. . .Abbott withdraws diet pill in US, Canada

turtlepower Share Friday, October 08, 2010 8:17:24 AM
Re: DewDiligence post# 97437 Tweet Post # of 105877

Boehringer Ends Female Desire Drug Development After FDA's Safety Query
By Naomi Kresge - Oct 8, 2010 3:55 AM ET
Tweet LinkedIn Share Print Email
Oct. 8 (Bloomberg) - Boehringer Ingelheim GmbH abandoned development of its female desire drug flibanserin after U.S. regulators said the pill wasn’t proven to be safe and effective.

Great. Just great. So now the whole country is going to be chock-full of obese, frigid women. As a result, no matter where you travel in this great land it will all appear like Milwaukee.

:-)

Bill

[DewDiligence]

ABT’s voluntary Meridia withdrawal makes you wonder about taxpayers’ time and money spent to convene an FDA advisory panel that ended in a tie vote.

[DewDiligence]

Meridia Factoids

• Annualized worldwide sales (prior to US withdrawal): approximately $100M.

• Annualized US sales (prior to withdrawal): approximately $25M.

• Decline in US sales from 1998 peak to just before withdrawal: 81%.

• ABT’s annualized US selling expenses prior to withdrawal: $0 (the drug wasn’t being promoted).

Source: http://online.wsj.com/article/SB10001424052748704657304575540041186476012.html